Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome.

PURPOSE The diagnostic and prognostic significance of well-defined molecular markers was investigated in childhood primitive neuroectodermal tumors (PNET). MATERIALS AND METHODS Using microsatellite analysis, Southern blot analysis, and fluorescence in situ hybridization (FISH), 30 primary tumors and six CSF metastasis specimens were analyzed for loss of heterozygosity (LOH) of chromosomes 1q31, 6q, 9q22, 10q, 11, 16q22, and 17p13.1 and/or high-level amplification of the c-myc gene. Experimental data were compared with clinical stage and outcome. RESULTS LOH of chromosome 17p13.1 was found most frequently (14 of 30 tumors, six of six CSF metastasis specimens); LOH of chromosomes 10q, 16q22, 11, 6, 9q22, and 1q31 was observed in 20.6%, 20%, 14.3%, 12%, 10%, and 0%, respectively. Eight of 32 tumors and CSF specimens showed amplification of c-myc. All tumors with amplification of c-myc were resistant to therapy and had a fatal outcome (mean survival time, 9.3 months). Tumors that displayed LOH of chromosome 17p were associated with metastatic disease. The prognosis of these tumors was worse only when associated with amplification of c-myc. Three of three patients with LOH of 9q22 relapsed. CONCLUSION In our study, amplification of c-myc was a poor-prognosis marker in PNET. LOH of chromosome 17p was associated with metastatic disease. Molecular analysis of primary tumors using these markers may be useful for stratification of children with PNET in future prospective studies. The other aberrations investigated were not of significant prognostic value, but may provide an entry point for future large-scale molecular studies.

[1]  A. Poustka,et al.  High‐resolution deletion mapping of chromosome arm 17p in childhood primitive neuroectodermal tumors reveals a common chromosomal disruption within the Smith‐Magenis region, an unstable region in chromosome band 17p11.2 , 1997, Genes, chromosomes & cancer.

[2]  D. Fults,et al.  Correlation of chromosome 17p loss with clinical outcome in medulloblastoma. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  A. von Deimling,et al.  Loss of heterozygosity at locus F13B on chromosome 1q in human medulloblastoma , 1996, International journal of cancer.

[4]  P. Lichter,et al.  Mapping of chromosomal gains and losses in primitive neuroectodermal tumors by comparative genomic hybridization , 1996, Genes, chromosomes & cancer.

[5]  Michael Dean,et al.  Mutations of the Human Homolog of Drosophila patched in the Nevoid Basal Cell Carcinoma Syndrome , 1996, Cell.

[6]  R. Myers,et al.  Human Homolog of patched, a Candidate Gene for the Basal Cell Nevus Syndrome , 1996, Science.

[7]  J. Shuster,et al.  High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  R. McLendon,et al.  Microsatellite analysis of childhood brain tumors , 1996, Genes, chromosomes & cancer.

[9]  A. Aguzzi,et al.  Deregulated expression of PAX5 in medulloblastoma. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[10]  S. Pomeroy,et al.  Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[11]  T. Hongo,et al.  Chromosome analysis of brain tumors in childhood , 1994, Genes, chromosomes & cancer.

[12]  O. Wiestler,et al.  Microsatellite analysis of loss of heterozygosity on chromosomes 9q, 11 p and 17p in medulloblastomas , 1994, Neuropathology and applied neurobiology.

[13]  M E Cohen,et al.  Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. , 1993, The New England journal of medicine.

[14]  J. Trojanowski,et al.  Medulloblastomas and related primitive neuroectodermal brain tumors of childhood recapitulate molecular milestones in the maturation of neuroblasts. , 1992, Molecular and chemical neuropathology.

[15]  P. Lichter,et al.  Variable breakpoints in Burkitt lymphoma cells with chromosomal t(8;14) translocation separate c-myc and the IgH locus up to several hundred kb. , 1992, Human molecular genetics.

[16]  J. Biegel,et al.  Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors. , 1992, Cancer research.

[17]  J. Murray,et al.  A tetranucleotide repeat for the F13B locus. , 1992, Nucleic acids research.

[18]  V. Sheffield,et al.  Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis. , 1992, American journal of human genetics.

[19]  G. Basso,et al.  N-MYC and C-MYC Oncogenes Amplification in Medulloblastomas. Evidence of Particularly Aggressive Behavior of a Tumor with C-MYC Amplification , 1991, Tumori.

[20]  C. Raffel,et al.  Loss of heterozygosity on 6q, 16q, and 17p in human central nervous system primitive neuroectodermal tumors. , 1991, Cancer research.

[21]  B. Vogelstein,et al.  Cytogenetics and Molecular Genetics of Malignant Gliomas and Medulloblastoma , 1990, Brain pathology.

[22]  W. J. Oakes,et al.  Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts. , 1990, Cancer research.

[23]  K. Weinberg,et al.  Reduction to homozygosity and gene amplification in central nervous system primitive neuroectodermal tumors of childhood. , 1990, Cancer research.

[24]  G Hermanson,et al.  High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. , 1990, Science.

[25]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[26]  Michael E. Cohen,et al.  A classification system for primitive neuroectodermal tumors (medulloblastoma) of the posterior fossa , 1985, Cancer.

[27]  H. Döhner,et al.  Detection of trisomy 8 on blood smears using fluorescence in situ hybridization. , 1993, Leukemia.

[28]  P. Cogen.  Prognostic significance of molecular genetic markers in childhood brain tumors. , 1991, Pediatric neurosurgery.